Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 71 (RPL21P71) is a processed pseudogene derived from the parent RPL21 gene, which encodes the 60S ribosomal protein L21, a component of the large ribosomal subunit involved in protein synthesis[1][2]. Pseudogenes like RPL21P71 do not produce functional proteins and are generally considered transcriptionally silent or nonfunctional genetic elements. Unlike the functional RPL21 gene, RPL21P71 does not participate in ribosome assembly, protein translation, or cellular processes. There is no evidence that this pseudogene is implicated in disease or used as a therapeutic target or biomarker in any known context[2][1]. If you are seeking information on the functional protein product or gene, refer to "60S ribosomal protein L21" (RPL21)[1][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 71 (RPL21P71).